Patents by Inventor Lennart Gustav Lundberg

Lennart Gustav Lundberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING JUVENILE ARTHRITIS WITH ANTI-BILE SALT-STIMULATED LIPASE (BSSL) ANTIBODIES
    Publication number: 20200291136
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Application
    Filed: May 29, 2020
    Publication date: September 17, 2020
    Inventors: Olle Hernell, Susanne Lindquist, Lennart Gustav Lundberg
  • METHODS FOR TREATING JUVENILE ARTHRITIS WITH ANTI-BILE SALT-STIMULATED LIPASE (BSSL) ANTIBODIES
    Publication number: 20160096899
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Application
    Filed: September 28, 2015
    Publication date: April 7, 2016
    Inventors: OLLE HERNELL, SUSANNE LINDQUIST, LENNART GUSTAV LUNDBERG
  • Methods for treating juvenile arthritis with ant-bile salt-stimulated lipase (BSSL) antibodies
    Patent number: 9168299
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: October 27, 2015
    Assignee: LIPUM AB
    Inventors: Olle Hernell, Susanne Lindquist, Lennart Gustav Lundberg
  • METHODS FOR TREATMENT OF INFLAMMATORY DISEASES
    Publication number: 20140099323
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Application
    Filed: October 30, 2013
    Publication date: April 10, 2014
    Inventors: OLLE HERNELL, SUSANNE LINDQUIST, LENNART GUSTAV LUNDBERG
  • Methods for treating rheumatoid arthritis with anti-bile salt-stimulated lipase (BSSL) antibodies
    Patent number: 8597650
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: December 3, 2013
    Inventors: Olle Hernell, Susanne Lindquist, Lennart Gustav Lundberg
  • NEW METHODS FOR TREATMENT OF INFLAMMATORY DISEASES
    Publication number: 20120093829
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Application
    Filed: April 6, 2010
    Publication date: April 19, 2012
    Inventors: Olle Hernell, Susanne Lindquist, Lennart Gustav Lundberg
  • Nucleic acids encoding BSSL variants
    Patent number: 5827683
    Abstract: The invention discloses nucleic acids encoding variant Bile Salt Stimulated Lipase (BSSL; EC 3.1.1.1). The encoded variant BSSL enzymes maintain catalytic activity but contain fewer glycosylation sites that full-length BSSL. This reduced glycosylation facilitates purification and characterization of recombinant BSSL proteins.
    Type: Grant
    Filed: March 1, 1994
    Date of Patent: October 27, 1998
    Assignee: Astra Aktiebolag
    Inventors: Lars Gustav Blackberg, Michael Edlund, Stig Lennart Hansson, Olle Carl Edward Hernell, Lennart Gustav Lundberg, Mats Olof Stromqvist, Jan Birger Fredrik Tornell
  • Transgenic non-human mammals producing BSSL variants
    Patent number: 5763739
    Abstract: The present invention relates to novel polypeptides which are variants of Bile Salt-Stimulated Lipase (BSSL; EC 3.1.1.1). It also relates to DNA molecules encoding the said polypeptides, and to subproducts comprising the said DNA molecules. The invention further relates to processes for producing the said BSSL variants and for producing transgenic non-human mammals capable of expressing the BSSL variants.Furthermore the invention relates to such transgenic animals as well as to infant formulas comprising milk from such transgenic animals. The invention also relates to pharmaceutical compositions comprising the said polypeptides; and the use of the said polypeptides and DNA molecules for the manufacture of medicaments.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: June 9, 1998
    Assignee: Astra Aktiebolag
    Inventors: Lars Gustav Blackberg, Michael Edlund, Stig Lennart Hansson, Olle Carl Edward Hernell, Lennart Gustav Lundberg, Mats Olof Stromqvist, Jan Birger Fredrik Tornell